Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Feb 17;13:1431–1445. doi: 10.2147/OTT.S227831

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Ding et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

CHK1 intervened in the effects of miR-424 on metastasis of glioma cells. (A) The invasive abilities of glioma cells were tested under the influence of NC, miR-mimic, miR-424 mimic and miR-424 mimic+pcDNA3.1-CHK1 groups. *: P<0.05 when compared with the NC group. (B) The glioma cells were appraised concerning their migratory capacity among NC, miR-mimic, miR-424 mimic and miR-424 mimic+pcDNA3.1-CHK1 groups. *: P<0.05 when compared with the NC group. (C) Expressions of EMT-related proteins were measured within glioma cells handled with NC, miR-mimic, miR-424 mimic and miR-424 mimic+pcDNA3.1-CHK1 groups. *: P<0.05 when compared with the NC group.